Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
Chemed Reports Third-Quarter 2025 Results
Enhabit Announces Participation in UBS Global Healthcare Conference 2025
LifeStance to Present at the UBS Global Healthcare Conference
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema
Vivani Medical, Inc. Announces Closing of Common Stock Offering
Ekso Bionics Reports Third Quarter 2025 Financial Results